The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
AI-Powered "GPS" Model Marks Paradigm Shift in Drug Discovery, Identifies Candidates for Liver Cancer and Pulmonary Fibrosis
A groundbreaking machine-learning model, dubbed "GPS" (Gene Expression Profile Predictor on Chemical Structures), has been unveiled by a multi-institute collaboration…
Read More
MEDVi’s Meteoric AI-Fueled Ascent Faces Scrutiny Amidst FDA Warnings, Allegations of Deceptive Marketing, and Multiple Lawsuits
A telehealth startup, MEDVi, recently lauded by The New York Times as a prime example of an AI-driven billion-dollar enterprise,…
Read More
Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
This groundbreaking research from the Johns Hopkins Kimmel Cancer Center marks a significant stride in the quest for more effective…
Read More
Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors
Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read More
Oxford-Led Research Unveils Revolutionary Food Supplement to Combat Honeybee Decline
A groundbreaking food supplement, engineered to precisely mimic the essential nutrients bees derive from natural pollen, has been developed by…
Read More
MIT Researchers Uncover How Exercise Directly Stimulates Nerve Growth Through Biochemical and Physical Signaling
In a landmark study that redefines our understanding of the relationship between the muscular and nervous systems, engineers at the…
Read More
Translating Life Science Innovation into Widespread Adoption: Insights from Industry Veteran Dale Gordon
Despite a vibrant landscape of scientific breakthroughs, a significant proportion of promising life science innovations struggle to achieve widespread adoption…
Read More
Pharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025
Merck’s Keytruda (pembrolizumab), a cornerstone of modern oncology, maintained its position as the pharmaceutical industry’s leading brand in Fiscal Year…
Read More
Unlocking the Brain’s Secret Role in Metformin’s Anti-Diabetic Effects: A New Frontier in Metabolic Research
For more than six decades, metformin has served as the cornerstone of pharmacological management for type 2 diabetes. Since its…
Read More
